CombiLac® is a high-performance co-processed excipient based on lactose, specially developed to simplify the development and manufacture of oral solid dosage forms.
MEGGLE CombiLac is a high-performance co-processed pharmaceutical excipient based on lactose, developed to simplify the development and production of oral solid dosage forms. It consists of 70% monohydrate lactose, 20% microcrystalline cellulose, and 10% white corn starch, integrated into a stable single-particle structure that does not disperse under external force. Compared to physical mixtures, CombiLac offers superior compressibility, making it suitable for high-hardness, low-friability tablet formulations.
The document details the product's advantages, including excellent flowability, rapid disintegration unaffected by hardness, and low friability. It provides technical data on particle size distribution, sorption isotherms, flowability, compactibility, and disintegration times, comparing CombiLac against physical mixtures and other co-processed excipients like MicroceLac and StarLac. The text also covers regulatory compliance, packaging, and shelf life. This manual is written in Chinese.
| Composition | 70% monohydrate lactose, 20% microcrystalline cellulose, 10% white corn starch |
|---|---|
| Particle Size (< 32 µm) | NMT 15 % |
| Particle Size (< 160 µm) | 35–65 % |
| Particle Size (< 250 µm) | NLT 85 % |
| BET Surface Area | 0.5 m2/g |
CombiLac is composed of 70% monohydrate lactose, 20% microcrystalline cellulose, and 10% white corn starch.
It offers excellent compressibility, superior flowability, rapid disintegration unaffected by hardness, and low friability.